Ya‐Gang Zuo

884 total citations
68 papers, 543 citations indexed

About

Ya‐Gang Zuo is a scholar working on Pathology and Forensic Medicine, Dermatology and Rheumatology. According to data from OpenAlex, Ya‐Gang Zuo has authored 68 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pathology and Forensic Medicine, 23 papers in Dermatology and 20 papers in Rheumatology. Recurrent topics in Ya‐Gang Zuo's work include Autoimmune Bullous Skin Diseases (35 papers), Urticaria and Related Conditions (19 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers). Ya‐Gang Zuo is often cited by papers focused on Autoimmune Bullous Skin Diseases (35 papers), Urticaria and Related Conditions (19 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers). Ya‐Gang Zuo collaborates with scholars based in China, United States and South Korea. Ya‐Gang Zuo's co-authors include Hongzhong Jin, Heyi Zheng, Jun Li, Dong‐Lai Ma, Yuehua Liu, Chun‐Xia He, Qiuning Sun, Chao Wu, Hongwei Wang and Zhi Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Plastic & Reconstructive Surgery.

In The Last Decade

Ya‐Gang Zuo

60 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ya‐Gang Zuo China 13 209 201 174 131 90 68 543
Narciss Mobini United States 13 253 1.2× 124 0.6× 169 1.0× 137 1.0× 63 0.7× 26 528
Emel Bülbül Başkan Türkiye 15 320 1.5× 248 1.2× 467 2.7× 245 1.9× 158 1.8× 72 865
Alice Verdelli Italy 13 151 0.7× 150 0.7× 141 0.8× 46 0.4× 51 0.6× 49 525
Irma Korom Hungary 14 148 0.7× 132 0.7× 106 0.6× 72 0.5× 46 0.5× 37 513
Farzan Solimani Germany 16 441 2.1× 293 1.5× 304 1.7× 185 1.4× 154 1.7× 40 881
Toshihiro Tanaka Japan 15 159 0.8× 160 0.8× 159 0.9× 59 0.5× 66 0.7× 65 681
Chika Ohata Japan 18 529 2.5× 236 1.2× 429 2.5× 350 2.7× 172 1.9× 75 924
Kathleen M. David-Bajar United States 15 215 1.0× 169 0.8× 297 1.7× 76 0.6× 174 1.9× 20 564
Emmanuelle Tancrède‐Bohin France 15 353 1.7× 159 0.8× 381 2.2× 269 2.1× 353 3.9× 31 1.1k
Toshikazu Usuda Japan 9 250 1.2× 98 0.5× 224 1.3× 104 0.8× 90 1.0× 22 447

Countries citing papers authored by Ya‐Gang Zuo

Since Specialization
Citations

This map shows the geographic impact of Ya‐Gang Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya‐Gang Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya‐Gang Zuo more than expected).

Fields of papers citing papers by Ya‐Gang Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya‐Gang Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya‐Gang Zuo. The network helps show where Ya‐Gang Zuo may publish in the future.

Co-authorship network of co-authors of Ya‐Gang Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Ya‐Gang Zuo. A scholar is included among the top collaborators of Ya‐Gang Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya‐Gang Zuo. Ya‐Gang Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Huihao, et al.. (2025). A Conceptual Review of Gut, Skin, and Oral Microbiota in Autoimmune Bullous Diseases: From Dysbiosis to Therapeutic Potential. Journal of Inflammation Research. Volume 18. 13925–13943.
2.
Yang, Li, et al.. (2025). Associated factors related to production of autoantibodies and dermo-epidermal separation in bullous pemphigoid. Archives of Dermatological Research. 317(1). 303–303.
3.
Liu, Sihan, et al.. (2024). Macrophages in inflammatory skin diseases and skin tumors. Frontiers in Immunology. 15. 1430825–1430825. 2 indexed citations
4.
Liu, Yuhua, et al.. (2023). Dupilumab effectively and rapidly treats bullous pemphigoid by inhibiting the activities of multiple cell types. Frontiers in Immunology. 14. 1194088–1194088. 10 indexed citations
5.
Zuo, Ya‐Gang, et al.. (2023). Successful treatment of alopecia universalis with abrocitinib: a case report. Journal of Dermatological Treatment. 34(1). 2242706–2242706. 13 indexed citations
6.
7.
Jin, Hongzhong, et al.. (2020). Treatment of bullous pemphigoid in Chinese patients withTripterygium wilfordiiHook F. Dermatologic Therapy. 33(4). e13721–e13721. 4 indexed citations
8.
Li, Li, et al.. (2017). Survey of the epidemiology of autoimmune bullous disorders in Peking Union Medical College Hospital: a 30-year review. European Journal of Dermatology. 27(3). 331–332. 2 indexed citations
9.
Jin, Hongzhong, et al.. (2017). Prevalence of metabolic syndrome in Chinese psoriasis patients: A hospital‐based cross‐sectional study. Journal of Diabetes Investigation. 9(1). 39–43. 40 indexed citations
10.
Zuo, Ya‐Gang, Donna A. Culton, Antonio Guilabert, et al.. (2016). IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid. Journal of Autoimmunity. 73. 111–119. 38 indexed citations
11.
Liu, Bing, et al.. (2015). Incidence of adverse cutaneous drug reactions in 22,866 Chinese inpatients: a prospective study. Archives of Dermatological Research. 307(9). 829–834. 9 indexed citations
12.
Zuo, Ya‐Gang, et al.. (2013). Bullous pemphigoid and cicatricial pemphigoid. International Journal of Dermatology and Venereology. 39(6). 347–350.
13.
Li, Jun, Ya‐Gang Zuo, & Heyi Zheng. (2013). Mortality of Bullous Pemphigoid in China. JAMA Dermatology. 149(1). 106–106. 33 indexed citations
14.
Zeng, Yueping, et al.. (2012). A recurrent missense mutation of keratin 1 gene in a Chinese family with epidermolytic hyperkeratosis (severe palmoplantar hyperkeratosis, type 1). International Journal of Dermatology. 51(2). 182–185. 3 indexed citations
15.
Lu, Yifan, et al.. (2010). Relationship of TAP-1 allele gene polymorphism to recurrent condyloma acuminatum. Chinese Journal of Dermatology. 43(5). 339–341. 1 indexed citations
16.
Zuo, Ya‐Gang, et al.. (2009). Lack of evidence forOSMRandRETgene mutations in a Chinese family with friction melanosis. Clinical and Experimental Dermatology. 35(3). 282–286. 3 indexed citations
17.
Wang, Hongwei, et al.. (2007). Analysis of 602 Chinese Cases of Nevus of Ota and the Treatment Results Treated by Q-Switched Alexandrite Laser. Dermatologic Surgery. 33(4). 455–460. 22 indexed citations
18.
Jin, Hongzhong, Hongwei Wang, Yuehua Liu, et al.. (2006). [Effectiveness and safety of long-pulsed Alexandrite laser for hair removal in 1702 patients].. PubMed. 28(2). 210–3. 2 indexed citations
19.
Liu, Fang, et al.. (2004). Construction and immunogenicity of human papillomavirus type 6b L1 recombinant plasmid.. PubMed. 19(3). 233–6. 1 indexed citations
20.
Yuan, Zhiqiang, et al.. (1999). SSA/Ro antigen expressed on membrane of UVB-induced apoptotic keratinocytes is pathogenic but not detectable in supernatant of cell culture.. Chinese Medical Journal. 112(6). 512–5. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026